ROCKET PHARMACEUTICALS, INC. (RCKT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, ROCKET PHARMACEUTICALS, INC. reported revenue of $0. The company ran a net loss. It held $330.45M in total assets against $53.23M in total liabilities.
Key ratios (FY2025)
-80.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$231.75M | -$273.20M | -$259.66M | -$224.34M | -$167.25M | -$134.30M | -$76.15M | -$71.16M | -$19.77M | -$7.57M |
| Net Income | -$223.12M | -$258.75M | -$245.59M | -$221.86M | -$169.07M | -$139.70M | -$77.27M | -$74.52M | -$19.58M | -$7.57M |
| EPS (Diluted) | $-2.01 | $-2.73 | $-2.92 | $-3.26 | $-2.67 | $-2.52 | $-1.58 | — | — | — |
| Total Assets | $330.45M | $527.70M | $566.34M | $551.81M | $497.02M | $590.82M | $372.12M | $251.31M | $20.15M | $129.65M |
| Total Liabilities | $53.23M | $64.47M | $73.77M | $62.12M | $42.30M | $87.31M | $64.82M | $57.28M | $4.63M | $56.48M |
| Shareholders' Equity | $277.22M | $463.23M | $492.57M | $489.69M | $454.72M | $503.52M | $307.30M | $194.04M | $15.52M | $8.37M |
| Cash & Equivalents | $77.56M | $163.63M | $55.90M | $140.52M | $232.69M | $297.10M | $185.38M | $111.36M | $18.14M | $29.80M |
| Operating Cash Flow | -$190.01M | -$209.72M | -$194.92M | -$178.14M | -$121.16M | -$74.64M | -$64.66M | -$53.79M | -$15.96M | -$5.50M |
| Capital Expenditures | $440.0K | $5.86M | $16.44M | $8.36M | $7.62M | $20.61M | $23.27M | $1.45M | $760.0K | $335.0K |
| Shares Outstanding | 108.32M | 106.45M | 90.28M | 79.12M | 64.51M | 61.00M | 54.77M | 45.14M | 6.80M | 6.75M |